Lundbeck
HLUN-B.CO
$5.44
Share price
0.43%
Change (1 day)
-1.90%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Lundbeck (HLUN-B.CO) - Cash on Hand
Cash on Hand as of December 2023 : $0.74 B
According to Lundbeck
's latest financial reports the company has $0.74 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lundbeck - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.74 B | 50.61% |
| 2022-12-31 | $0.49 B | 41.98% |
| 2021-12-31 | $0.34 B | -46.51% |
| 2020-12-31 | $0.64 B | 43.63% |
| 2019-12-31 | $0.45 B | -55.58% |
| 2018-12-31 | $1.01 B | 71.49% |
| 2017-12-31 | $0.59 B | 88.84% |
| 2016-12-31 | $0.31 B | 40.83% |
| 2015-12-31 | $0.22 B | -62.8% |
| 2014-12-31 | $0.59 B | -44.76% |
| 2013-12-31 | $1.08 B | 60.9% |
| 2012-12-31 | $0.67 B | -1.86% |
| 2011-12-31 | $0.68 B | 63.93% |
| 2010-12-31 | $0.41 B | 7.74% |
| 2009-12-31 | $0.38 B | -46.56% |
| 2008-12-31 | $0.72 B | 109.88% |
| 2007-12-31 | $0.34 B | 66.22% |
| 2006-12-31 | $0.20 B | 187.63% |
| 2005-12-31 | $72.53 M | -26.46% |
| 2004-12-31 | $98.63 M |